These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8692823)

  • 1. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency.
    Emiliani S; Van Lint C; Fischle W; Paras P; Ott M; Brady J; Verdin E
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6377-81. PubMed ID: 8692823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys.
    Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B
    Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication.
    Harrich D; Mavankal G; Mette-Snider A; Gaynor RB
    J Virol; 1995 Aug; 69(8):4906-13. PubMed ID: 7609059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.
    Verhoef K; Tijms M; Berkhout B
    Nucleic Acids Res; 1997 Feb; 25(3):496-502. PubMed ID: 9016587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells.
    Zhu M; Duan L; Pomerantz RJ
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1093-101. PubMed ID: 8844014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones.
    Kim JH; McLinden RJ; Mosca JD; Burke DS; Boswell RN; Birx DL; Redfield RR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):329-42. PubMed ID: 8673541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
    Modesti N; Garcia J; Debouck C; Peterlin M; Gaynor R
    New Biol; 1991 Aug; 3(8):759-68. PubMed ID: 1931822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.
    Williams SA; Kwon H; Chen LF; Greene WC
    J Virol; 2007 Jun; 81(11):6043-56. PubMed ID: 17376917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells.
    Kim YS; Panganiban AT
    J Neurosci Res; 1996 Mar; 43(6):652-66. PubMed ID: 8984195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism.
    Biswas DK; Tius MA; Zhuo J; Pardee AB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):120-7. PubMed ID: 8680882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line.
    Emiliani S; Fischle W; Ott M; Van Lint C; Amella CA; Verdin E
    J Virol; 1998 Feb; 72(2):1666-70. PubMed ID: 9445075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single amino acid change in Tat determines the different rates of replication of two sequential HIV-1 isolates.
    LeGuern M; Shioda T; Levy JA; Cheng-Mayer C
    Virology; 1993 Aug; 195(2):441-7. PubMed ID: 8337822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.
    Churcher MJ; Lowe AD; Gait MJ; Karn J
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2408-12. PubMed ID: 7892280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant.
    Balboni PG; Bozzini R; Zucchini S; Marconi PC; Grossi MP; Caputo A; Manservigi R; Barbanti-Brodano G
    J Med Virol; 1993 Dec; 41(4):289-95. PubMed ID: 8106862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.